NP49119 Hepatitis C Medicines

A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")

Source
Find a Tender
Type
Framework (Goods)
Duration
not specified
Value
£6M
Sector
HEALTH
Published
28 Feb 2023
Delivery
not specified
Deadline
n/a

Concepts

Location

All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014

Geochart for 1 buyers and 5 suppliers

1 buyer

3 suppliers

Description

This Framework Agreement is for the supply of medicines used in the treatment of Hepatitis C to NHSScotland. It includes both a treatment cost per medicine and a treatment spend cap.

Lot Division

1 Treatment Cost per Medicine

This Lot is for the treatment cost per medicine.
2 Treatment Spend Cap

This Lot is for the treatment spend cap.

Award Detail

1 Abbvie (Maidenhead)
  • Treatment Cost per Medicine
  • Reference: 005777-2023-1
  • Value: £5,873,754 [share]
  • Awarded to group of suppliers.
2 Gilead Sciences (London)
  • Treatment Cost per Medicine
  • Reference: 005777-2023-1
  • Value: £5,873,754 [share]
  • Awarded to group of suppliers.
3 Merck Sharp & Dohme (Hoddesdon)
  • Treatment Cost per Medicine
  • Reference: 005777-2023-1
  • Value: £5,873,754 [share]
  • Awarded to group of suppliers.
4 Abbvie (Maidenhead)
  • Treatment Spend Cap
  • Reference: 005777-2023-2
  • Value: £5,873,754 [share]
  • Awarded to group of suppliers.
5 Gilead Sciences (London)
  • Treatment Spend Cap
  • Reference: 005777-2023-2
  • Value: £5,873,754 [share]
  • Awarded to group of suppliers.

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated value(s) referred to in Section II.I.7 and each Lot covers the twelve (12) month modification period of the framework agreement. (SC Ref:720879)

Reference

Domains